ZNF442 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62880819942757E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.71764857681956E-13 |
Normal-vs-Stage2 |
5.84243764478742E-12 |
Normal-vs-Stage3 |
1.62447832963153E-12 |
Normal-vs-Stage4 |
1.11022302462516E-16 |
Stage1-vs-Stage2 |
4.628000E-01 |
Stage1-vs-Stage3 |
8.24409995825448E-09 |
Stage1-vs-Stage4 |
4.571400E-04 |
Stage2-vs-Stage3 |
1.105780E-02 |
Stage2-vs-Stage4 |
7.648300E-02 |
Stage3-vs-Stage4 |
3.053400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62825308791525E-12 |
Normal-vs-AfricanAmerican |
7.8704820438702E-12 |
Normal-vs-Asian |
2.968500E-02 |
Caucasian-vs-AfricanAmerican |
5.861200E-01 |
Caucasian-vs-Asian |
8.462000E-02 |
AfricanAmerican-vs-Asian |
2.220000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.0325074129014E-14 |
Normal-vs-Female |
1.4432899320127E-15 |
Male-vs-Female |
3.219600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.07739994703593E-09 |
Normal-vs-Age(41-60Yrs) |
1.66078262253677E-12 |
Normal-vs-Age(61-80Yrs) |
9.99200722162641E-16 |
Normal-vs-Age(81-100Yrs) |
2.27129426377815E-12 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.746000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.680400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.317400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.944000E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.345600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.184200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.120400E-03 |
Normal-vs-Grade 2 |
1.15929488231359E-12 |
Normal-vs-Grade 3 |
4.44089209850063E-16 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
3.377200E-01 |
Grade 1-vs-Grade 3 |
8.619900E-02 |
Grade 1-vs-Grade 4 |
1.633540E-02 |
Grade 2-vs-Grade 3 |
1.572590E-04 |
Grade 2-vs-Grade 4 |
9.64909999678909E-08 |
Grade 3-vs-Grade 4 |
9.428100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.8428591985753E-12 |
Normal-vs-ccB subtype |
1.62470037423645E-12 |
ccA subtype-vs-ccB subtype |
1.443610E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.1094237467878E-15 |
Normal-vs-N1 |
7.53859996649453E-09 |
N0-vs-N1 |
2.336600E-01 |
|
|